9 Meters Biopharma Inc. (NMTR)
NASDAQ: NMTR
· Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM
9 Meters Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -12.79M | -10.74M | -8.72M | -11.2M | -11.36M | -9.56M | -13.54M | -8.26M | -5.4M |
Interest Income | 164.79K | 291.44K | 131.66K | 65.32K | 12.81K | 9.72K | 1.4K | 6.5K | 5.09K |
Pretax Income | -13.87M | -11.93M | -9.35M | -11.13M | -11.35M | -9.55M | -13.54M | -8.25M | -5.43M |
Net Income | -15.7M | -13.04M | -9.99M | -11.06M | -11.34M | -9.55M | -13.54M | -8.25M | -5.43M |
Selling & General & Admin | 2.99M | 1.95M | 2.42M | 3.65M | 3M | 2.52M | 2.39M | 2.55M | 2.21M |
Research & Development | 9.8M | 8.79M | 6.3M | 7.55M | 8.37M | 7.05M | 6.05M | 5.71M | 3.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.79M | 10.74M | 8.72M | 11.2M | 11.36M | 9.56M | 8.44M | 8.26M | 5.4M |
Interest Expense | 752.82K | 1.82M | 847.34K | 65.32K | 304.00 | n/a | 1.97K | 1.15K | 44.06K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.79M | 10.74M | 8.72M | 11.2M | 11.36M | 9.56M | 8.44M | 8.26M | 5.4M |
Income Tax Expense | 1.83M | 1.11M | 638.69K | -65.32K | -12.51K | 9.72K | 1.97K | 6.5K | 44.06K |
Shares Outstanding (Basic) | 13.59M | 12.96M | 12.96M | 12.95M | 12.91M | n/a | 12.71M | 12.48M | 10.56M |
Shares Outstanding (Diluted) | 13.59M | 12.96M | 12.96M | 12.95M | 12.91M | n/a | 12.71M | 12.48M | 10.56M |
EPS (Basic) | -1.16 | -1.01 | -0.77 | -0.85 | -0.88 | n/a | -1.06 | -0.66 | -0.51 |
EPS (Diluted) | -1.16 | -1.01 | -0.77 | -0.85 | -0.88 | n/a | -1.06 | -0.66 | -0.51 |
EBITDA | -12.62M | -10.45M | -8.58M | -11.13M | -11.35M | -9.55M | -8.43M | -8.25M | -5.39M |
EBIT | -13.12M | -10.11M | -8.51M | -11.06M | -11.35M | n/a | -13.54M | -8.25M | -5.39M |
Depreciation & Amortization | 166.12K | 293.98K | 133.22K | 68.11K | 14.44K | 2.92K | 1.33K | 2.22K | 1.11K |